| 1 |
Efficacy and safety of ebastine dose escalation in chronic urticaria: A prospective study |
|
| | Tian Qian, Shifei Li, Qiquan Chen, Daojun Zhang, Zhiqiang Song, Fei Hao | | | Dermatologic Therapy. 2022; | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Current approaches used in treating COVID-19 from a molecular mechanisms and immune response perspective |
|
| | Alaa Alnefaie, Sarah Albogami | | | Saudi Pharmaceutical Journal. 2020; 28(11): 1333 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
EBASTINE. A REASONABLE CHOICE |
|
| | I S Gushchin, I V Danilicheva | | | Russian Journal of Allergy. 2017; 14(4-5): 89 | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Comparative efficacy of non-sedating antihistamine updosing in patients with chronic urticaria |
|
| | Mario Sánchez-Borges,Ignacio Ansotegui,Jorge Jimenez,Maria Rojo,Carlos Serrano,Anahí Yañez | | | World Allergy Organization Journal. 2014; 7(1): 33 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Treatment of recalcitrant chronic urticaria with nonsedating antihistamines: Is there evidence for updosing? |
|
| | Sánchez-Borges, M., Caballero-Fonseca, F., Capriles-Hulett, A. | | | Journal of Investigational Allergology and Clinical Immunology. 2013; 23(3): 141-144 | | | [Pubmed] [Google Scholar] | |
|
